SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Viren Vaghela
Health
AstraZeneca-Oxford COVID vaccine could get U.K. approval as soon as this week
By
Viren Vaghela
,
Thomas Penny
, and others
Finance
COVID put electronic trading to the test. It’s never buckled, Goldman Sachs says
By
Viren Vaghela
and
Bloomberg
Finance
In London, a Europe-heavy stock exchange is facing down Brexit
By
Silla Brush
,
Viren Vaghela
, and others
International
Banks are moving $1.6 trillion in assets out of the U.K. ahead of Brexit cutoff
By
Bloomberg
and
Viren Vaghela
Finance
London’s LSE Formally Rejects Hong Kong Exchange’s Surprise $37 Billion Bid
By
Viren Vaghela
and
Bloomberg
International
London Stock Exchange Places $27 Billion Bet on a Data-Driven Future
By
Viren Vaghela
and
Bloomberg